Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03731442 |
|
Recruitment Status :
Recruiting
First Posted : November 6, 2018
Last Update Posted : December 12, 2018
|
Sponsor:
Chinese Academy of Medical Sciences
Collaborators:
The First Affiliated Hospital with Nanjing Medical University
Tianjin Medical University Cancer Institute and Hospital
Anyang Tumor Hospital
Fujian Cancer Hospital
Peking University Cancer Hospital & Institute
Hebei Medical University Fourth Hospital
Information provided by (Responsible Party):
Zefen Xiao, Chinese Academy of Medical Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 31, 2022 |
| Estimated Study Completion Date : | October 31, 2027 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):